MARK L. SANZ, MD
Osteopathic Medicine at Broadway St, Missoula, MT
License number
Montana 6285
Category
Osteopathic Medicine
Type
Cardiovascular Disease
License number
Montana MD60556860
Category
Osteopathic Medicine
Type
Interventional Cardiology
License number
Montana 6285
Category
Osteopathic Medicine
Type
Interventional Cardiology
Address
Address
500 W Broadway St SUITE 320, Missoula, MT 59802
Phone
(406) 329-5615
(406) 329-5606 (Fax)
(406) 329-5606 (Fax)
Organization information
See more information about MARK L. SANZ at bizstanding.comInternational Heart Institute Of Mount - Mark L Sanz MD
500 W Broadway St STE 320, Missoula, MT 59802
Categories:
Cardiology Physicians & Surgeons, Physicians & Surgeons
Site:
Phone:
(406) 329-5615 (Phone), (877) 444-5615 (Free)
In business since:
1979
Brands:
Premier
Products:
Adult Cardiology, Angioplasty, Cardiac Surgery, ...
Additional:
Providing Over, 30 Years of Excellence, A Division of SP St. Patrick Hospital and Health Sciences Center, Most Advanced Diagnostic Imaging Available Services Available Throughout Western Montana, Awar...
Professional information
See more information about MARK L. SANZ at trustoria.com
Dr. Mark L Sanz, Missoula MT - MD (Doctor of Medicine)
Dr. Mark L Sanz, Missoula MT - MD (Doctor of Medicine)
Specialties:
Cardiology, Interventional Cardiology
Address:
500 W Broadway St SUITE 320, Missoula 59802
(406) 329-5615 (Phone)
(406) 329-5615 (Phone)
Certifications:
Cardiovascular Disease, 1987, Internal Medicine, 1984, Interventional Cardiology, 2011
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
500 W Broadway St SUITE 320, Missoula 59802
Saint Patrick Hospital
500 West Broadway St, Missoula 59802
Saint Patrick Hospital
500 West Broadway St, Missoula 59802
Education:
Medical School
University Of Chicago/The Pritzker School Of Medicine
Graduated: 1980
University Colo Hospital
Graduated: 1981
Presby Denver Hospital
Graduated: 1985
Graduated: 1982
University Of Michigan
Graduated: 1988
University Of Chicago/The Pritzker School Of Medicine
Graduated: 1980
University Colo Hospital
Graduated: 1981
Presby Denver Hospital
Graduated: 1985
Graduated: 1982
University Of Michigan
Graduated: 1988
Mark Louis Sanz, Missoula MT
Mark Louis Sanz, Missoula MT
Specialties:
Internal Medicine, Cardiovascular Disease, Interventional Cardiology, Cardiology, Surgery, Thoracic Surgery, Cardiothoracic Vascular Surgery
Work:
The International Heart Institute Montana
500 W Broadway St, Missoula, MT 59802 International Heart Institute of Montana
435 S Crystal St, Butte, MT 59701
500 W Broadway St, Missoula, MT 59802 International Heart Institute of Montana
435 S Crystal St, Butte, MT 59701
Education:
University of Chicago (1980)
System, Including Method And Apparatus For Percutaneous Endovascular Treatment Of Functional Mitral Valve Insufficiency
System, Including Method And Apparatus For Percutaneous Endovascular Treatment Of Functional Mitral Valve Insufficiency
US Patent:
2006028, Dec 14, 2006
Filed:
Jun 6, 2006
Appl. No.:
11/447648
Inventors:
Carlos Duran - Missoula MT, US
Mark Sanz - Missoula MT, US
Jose Martinez de Ubago - Missoula MT, US
Yon Patrik de Ubago - Missoula MT, US
Mark Sanz - Missoula MT, US
Jose Martinez de Ubago - Missoula MT, US
Yon Patrik de Ubago - Missoula MT, US
International Classification:
A61F 2/06, A61M 29/02, A61F 2/94
US Classification:
600037000, 623001150, 606194000, 623001210
Abstract:
Among the four heart valves, the mitral is the most frequently affected by disease resulting in defective valve opening (stenosis) or incomplete closure (insufficiency). Most often this is due to distortion of the valve apparatus secondary to rheumatic or degenerative disease. These lesions, called “organic” require open heart surgery. In patients with coronary disease or with dilated cardiomyopathy the mitral valve can be insufficient although structurally normal. These valves are “functionally” insufficient. Because of the poor condition of these patients where open heart surgery carries a significant operative risk, less invasive percutaneous alternatives are being explored today. The present novel invention represents a radical departure from other procedures because it repositions the posterior papillary muscle utilizing a device located in the interventricular veins.
Sigmoid Valve And Method For Its Percutaneous Implantation
Sigmoid Valve And Method For Its Percutaneous Implantation
US Patent:
2004021, Oct 28, 2004
Filed:
Apr 11, 2003
Appl. No.:
10/411797
Inventors:
Carlos Duran - Missoula MT, US
Mark Sanz - Missoula MT, US
Mark Sanz - Missoula MT, US
International Classification:
A61F002/06
US Classification:
623/001240
Abstract:
A multi-leaflet valve adapted to serve as a prosthesis for diseased native valve of a mammal is incorporated in self-expandable or inflatable endovascular stents or stents to form a combination which is introduced on a catheter with a guide wire into the circulatory system of the mammal to replace the diseased native valve. Once the combination is at the desired location the stent is caused to expand and affix itself to the patient's vessel wall. The prosthetic valve has the shape of a truncated cone that has an inflow and an outflow orifice with leaflets forming the outflow orifice and forming a plurality of commissures. A first flexible circular support is affixed in a substantially circular fashion around the truncated cone in proximity of the inflow orifice, and a second flexible circular support is affixed at the location of the commissures to form a circle around the truncated cone in proximity of the outflow orifice. The circular supports maintain the shape of the valve during the surgical implantation procedure and thereafter.